Soru

Zorluk: OrtaMenstrual Cycle Abnormalities and Contraception

An evaluation is requested for a 47-year-old female patient who desires reliable contraception. She reports a 9-month history of erratic, heavy menstrual cycles. Menses occur unpredictably every 3 to 6 weeks, lasting up to 12 days, and are accompanied by the passage of large clots. The patient's medical history includes chronic hypertension and tobacco use disorder, smoking approximately 20 cigarettes per day. Current medications include lisinopril. Vital signs show a blood pressure of 144/92 mmHg, pulse of 82/min, and a body mass index of 35 kg/m235\text{ kg/m}^2. Pelvic examination demonstrates a parous, normal-appearing cervix and a globally enlarged, non-tender uterus. A urine pregnancy test is negative. Laboratory studies indicate a hemoglobin level of 9.8 g/dL. Pelvic ultrasonography reveals a heterogeneous endometrial echo complex measuring 16 mm16\text{ mm} in thickness with cystic changes. The patient is interested in starting a contraceptive method that will also alleviate her heavy bleeding. Which of the following is the most appropriate next step in the care of this patient?

  1. Endometrial biopsyCevap
  2. B
    Placement of a levonorgestrel-releasing intrauterine device
  3. C
    Prescription of a combined ethinyl estradiol and norethindrone pill
  4. D
    Placement of a copper T380A intrauterine device
  5. E
    Measurement of serum follicle-stimulating hormone level

Cevap

The most appropriate next step is to perform an endometrial biopsy.
This patient presents with abnormal uterine bleeding (AUB), characterized by erratic, heavy menses and a thickened, heterogeneous endometrium. According to current guidelines, any woman age 45 or older with AUB requires an endometrial biopsy as the mandatory initial diagnostic step to rule out endometrial hyperplasia or carcinoma. Although the patient's primary goals are contraception and cycle control, establishing a tissue diagnosis is a critical prerequisite. Once malignancy is excluded, she could be treated with a levonorgestrel-releasing IUD, which is an excellent option for both contraception and reducing menstrual blood loss.

Adım Adım Çözüm

1
Analyze the patient's age and bleeding pattern.
The patient is 47 years old with abnormal uterine bleeding (AUB) and symptomatic anemia.
Age ≥45\ge 45 years is a primary risk factor for endometrial hyperplasia and carcinoma when presenting with AUB.
2
Evaluate the ultrasound findings.
The endometrium is markedly thickened at 16 mm16\text{ mm} with heterogeneous changes.
A thickened endometrium in a perimenopausal woman with chronic anovulation and obesity strongly warrants tissue sampling.
3
Determine the immediate clinical priority before providing treatment.
An endometrial biopsy must be performed first.
Medical or surgical management of AUB cannot safely proceed without first excluding premalignant or malignant pathology.
4
Assess the patient's contraceptive eligibility for future planning.
Combined oral contraceptives are absolutely contraindicated.
The patient is >35>35 years old and smokes ≥15\ge 15 cigarettes daily, categorizing estrogen use as WHO Medical Eligibility Criteria (MEC) Category 4.

Anahtar Kavram

Evaluation of abnormal uterine bleeding (AUB) in women age 45 and older requires an endometrial biopsy to exclude hyperplasia or cancer before initiating medical therapy or contraception.
Tahmini Süre:1m 15s
Bu soruyu puanla